Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)
Name:
Garrassino.pdf
Size:
190.9Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Garassino, M. C.Mazieres, J.
Reck, M.
Chouaid, C.
Bischoff, H.
Reinmuth, N.
Cove-Smith, Laura
Mansy, T.
Cortinovis, D.
Migliorino, M. R.
Delmonte, A.
Sanchez, J. G.
Velarde, L. E. C.
Bernabe, R.
Paz-Ares, L.
Perez, I. D.
Trunova, N.
Foroutanpour, K.
Faivre-Finn, Corinne
Issue Date
2022
Metadata
Show full item recordCitation
Garassino MC, Mazieres J, Reck M, Chouaid C, Bischoff H, Reinmuth N, et al. 108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6). Vol. 33, Annals of Oncology. Elsevier BV; 2022. p. S81–2.Journal
Annals of OncologyDOI
10.1016/j.annonc.2022.02.135Additional Links
https://dx.doi.org/10.1016/j.annonc.2022.02.135Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.annonc.2022.02.135